JAX-NYSCF Conference Agenda
JAX-NYSCF Conference Agenda
Registration
Welcome Remarks
Lon Cardon, Ph.D., FMedSci
The Jackson Laboratory
President and CEO
Mary Dickinson, Ph.D.
The Jackson Laboratory
Executive Vice President and Chief Scientific Officer
Susan L. Solomon Memorial Keynote Address
Elaine Fuchs, Ph.D.
Howard Hughes Medical Institute, The Rockefeller University
Tissue stem cells: Coping with stress and its consequences
Break
Aging & Rejuvenation
Chair: Lee Rubin, Ph.D. – Harvard University
Juan Carlos Izpisua Belmonte, Ph.D.
Altos Labs
Break
Panel: Bridging Cellular and Animal Models
Sponsored by STEMCELL Technologies
Moderator: Mary Dickinson, Ph.D. – The Jackson Laboratory
California Institute for Regenerative Medicine
FUJIFILM Cellular Dynamics, Inc.
Complimentary Lunch
Neurodevelopment
Chair: Vikram Khurana, M.D., Ph.D. – Mass General Brigham and Harvard Medical School
Kristen Brennand, Ph.D.
Yale University; NYSCF – Robertson Stem Cell Investigator Alum
Gene x Environment Interactions in Brain Disease
University of California, San Francisco
Genomic insights into the development, evolution, and diseases of the developing human neocortex
Flora Vaccarino, M.D.
Yale University
Reconstructing human development with somatic mutations
Break
Short Talks Selected from Abstracts
Silvia Bolognin
Maastricht University
Modelling Senescence-Associated Features in Human Midbrain Systems through Replicative Exhaustion of Neural Progenitors
Selene Lomoio, Ph.D.
Icahn School of Medicine at Mount Sinai
Decoding axonopathy across neurodegenerative diseases with a modular human iPSC microfluidic platform
Kalai Mangai Muthukumarasamy, Ph.D.
The Jackson Laboratory
High-throughput cytotoxicity and cardiotoxicity evaluation in hiPSC-derived cardiomyocytes using combined cytotoxicity assays and non-invasive image-based phenotyping
Mohammed Toufiq
The Jackson Laboratory, University of Connecticut
Isoform-level profiling reveals age-associated inflammatory and epithelial remodeling programs in human tracheobronchial progenitor cells
Sicong Wang
Stanford University School of Medicine
Xenophagocytosis blockade enhances interspecies chimerism
Break
Keynote I
Alexander Meissner, Ph.D.
Max Planck Institute for Molecular Genetics;
NYSCF – Robertson Stem Cell Investigator Alum
Epigenetic regulation in development and disease
Poster Session
Registration
Opening Remarks
Mary Dickinson, Ph.D.
The Jackson Laboratory
Executive Vice President and Chief Scientific Officer
Announcement of Poster Awards
Keynote II
Marius Wernig, M.D., Ph.D.
Stanford University; NYSCF – Robertson Stem Cell Investigator Alum
Neural Microtissues: The Lego approach to study the brain
Break
Rare Disease and Gene Editing Advances
Chair: Frank Soldner, M.D. – Albert Einstein College of Medicine
Andrew Bassett, Ph.D.
Wellcome Sanger Institute
A CRISPR way to understand neurodegeneration
Cathleen (Cat) Lutz, Ph.D., M.B.A.
The Jackson Laboratory
Advances in gene editing—Is it all in the delivery?
Bill Skarnes, Ph.D.
The Jackson Laboratory
Break
Panel: New Approach Methods
Moderator: Stefan Semrau, Ph.D. – The Jackson Laboratory
Shuibing Chen, Ph.D.
Weill Cornell Medicine
Prabhakar Pandian, Ph.D.
GSK
National Institute on Aging
Complimentary Lunch
Translational Cell Therapies
Sponsored by Ajinomoto
Chair: Timothy A Blenkinsop, PhD – Icahn School of Medicine at Mount Sinai
Gabi Belfort, M.D., Ph.D.
BlueRock Therapeutics
Continued evaluation of participants with Parkinson’s disease 3 years after Bemdaneprocel administration, and design of a Phase 3 trial.
Malin Parmar, Ph.D.
Lund University; NYSCF – Robertson Stem Cell Investigator Alum
STEM-PD: A stem cell-based therapy for Parkinson’s Disease
Neural Stem Cell Institute
From Stem Cell Discovery to the Clinic, Developing a Therapy
for Age-Related Macular Degeneration
Break
New Technologies for iPSCs
Chair: Daniel Paull, Ph.D. – The Jackson Laboratory
Kristin Baldwin, Ph.D.
Columbia University
Building bespoke brain chimeras with accelerated reprogramming.
Gray Camp, Ph.D.
Exploring uniquely human biology with stem cells and single-cell technologies
Harvard University